Effect of food on the pharmacokinetics of a new hydroxypropyl-β-cyclodextrin formulation of itraconazole

Pharmacotherapy

Volumn 16, Issue 3 I, 1996, Pages 424-428

  Van De Velde, Vera J S ^a   Van Peer, Achiel P ^a   Heykants, Joseph J P ^a   Woestenborghs, Robert J H ^a   Van Rooy, Patricia ^a   De Beule, Karel L ^a   Cauwenbergh, Geert F M J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN DERIVATIVE; ITRACONAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; FEMALE; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; CROSS-OVER STUDIES; DEXTRINS; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED;

EID: 0029943565     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cauwenbergh G, De Doncker P, Stoops K, et al. Itraconazole in the treatment of human mycoses:review of three years of clinical experience. Rev Infect Dis 1987;9(suppl 1):S146-52.
2. Cauwenbergh G, De Doncker P. The clinical use of itraconazole in superficial and deep mycoses. In:Fromtling RA, ed. Recent trends in the discovery, development and evaluation of antifungal therapy. Barcelona:JR Prous, 1987:113-24.
3. Richardson MD, Warnock DW. Fungal infection. Diagnosis and management. London:Blackwell, 1993:30-1.
4. Cauwenbergh G, Degreef H, Heykants J, et al. Pharmacokinetic profile of orally administered ilraconazole in human skin. J Am Acad Dermatol 1988;18:263-8.
5. Polak A. Mode of action studies. In:Handbook of experimental pharmacology, vol 96. Berlin:Springer-Verlag, 1990:152-82.
6. Heykants J, Van Peer A, Van de Velde V, et al. The clinical pharmacokinetics of itraconazole:an overview. Mycoses 1989;32(suppl 1):67-87,
7. Barone JA, Koh JG, Bierman RH, et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicroh Agents Chemother 1993;37:778-84.
8. Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. New York:Marcel Dekker, 1982.
9. SAS Institute. User's guide. Statistics, vol 2, 4th ed, version 6.06. Cary, NC:Author, 1990.
10. Steinijans VW, Diletti E. Statistical analysis of bioavailability studies:parametric and nonparametric confidence intervals. Eur J Clin Pharmacol 1983;24:127-36.
11. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987;15:657-80.
12. Van Peer A, Woestenborghs R, Heykants J, et al. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects. EurJ Clin Pharmacol 1989;36:423-6.
13. Hardin TC, Graybill JR, Fetchick R, et al. Pharmacokinetics of itraconazole following oral administration to normal volunteers. Anlimicrob Agents Chemother 1988;32:1310-13.